Načítá se...

Randomized Comparison of Allogeneic Vs. Autologous Mesenchymal Stem Cells for Non-lschemic Dilated Cardiomyopathy: POSEIDON-DCM Trial

BACKGROUND: While human mesenchymal stem cells (hMSCs) have been tested in ischemic cardiomyopathy, few studies exist in chronic non-ischemic dilated cardiomyopathy (NIDCM). OBJECTIVES: The POSEIDON-DCM trial is a randomized comparison of safety and efficacy of autologous (auto) vs. allogeneic (allo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Coll Cardiol
Hlavní autoři: Hare, Joshua M., DiFede, Darcy L, Castellanos, Angela M, Florea, Victoria, Landin, Ana M, El-Khorazaty, Jill, Khan, Aisha, Mushtaq, Muzammil, Lowery, Maureen H, Byrnes, John J, Hendel, Robert C, Cohen, Mauricio G, Alfonso, Carlos E, Valasaki, Krystalenia, Pujol, Marietsy V, Golpanian, Samuel, Ghersin, Eduard, Fishman, Joel E, Pattany, Pradip, Gomes, Samirah A, Delgado, Cindy, Miki, Roberto, Abuzeid, Fouad, Vidro-Casiano, Mayra, Premer, Courtney, Medina, Audrey, Porras, Valeria, Hatzistergos, Konstantinos E., Anderson, Erica, Mendizabal, Adam, Mitrani, Raul, Heldman, Alan W.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291766/
https://ncbi.nlm.nih.gov/pubmed/27856208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2016.11.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!